-
EP2415765
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2415765
| EP2415765 - PYRIMIDINE COMPOUND [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.02.2015 Database last updated on 02.11.2024 | Most recent event Tooltip | 20.02.2015 | Application deemed to be withdrawn | published on 25.03.2015 [2015/13] | Applicant(s) | For all designated states Astellas Pharma Inc. 3-11, Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8411 / JP | [2012/06] | Inventor(s) | 01 /
MATSUSHIMA, Yuji c/o Astellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8411 / JP | 02 /
KUBOTA, Hirokazu c/o Astellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8411 / JP | 03 /
HAMAGUCHI, Hisao c/o Astellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8411 / JP | 04 /
OKAMOTO, Yoshinori c/o Astellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8411 / JP | 05 /
HONDO, Takeshi c/o Astellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8411 / JP | 06 /
NISHIGAKI, Fusako c/o Astellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8411 / JP | [2012/06] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastrasse 30 81925 München / DE | [N/P] |
| Former [2012/06] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | Application number, filing date | 10758605.9 | 29.03.2010 | WO2010JP55506 | Priority number, date | JP20090082282 | 30.03.2009 Original published format: JP 2009082282 | [2012/06] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010113834 | Date: | 07.10.2010 | Language: | JA | [2010/40] | Type: | A1 Application with search report | No.: | EP2415765 | Date: | 08.02.2012 | Language: | EN | [2012/06] | Search report(s) | International search report - published on: | JP | 07.10.2010 | (Supplementary) European search report - dispatched on: | EP | 17.07.2012 | Classification | IPC: | C07D407/12, C07D401/06, C07D417/06, C07D401/04, C07D239/48, A61K31/506, A61P29/00 | [2012/33] | CPC: |
C07D239/42 (EP,US);
C07D405/12 (EP,KR,US);
A61K31/506 (KR);
A61P1/02 (EP);
A61P1/04 (EP);
A61P1/08 (EP);
A61P1/10 (EP);
A61P1/12 (EP);
A61P1/14 (EP);
A61P1/16 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P11/14 (EP);
A61P13/10 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P15/08 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/04 (EP);
A61P17/06 (EP);
A61P17/16 (EP);
A61P19/02 (EP);
A61P19/04 (EP);
A61P19/06 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P21/02 (EP);
A61P21/04 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/04 (EP);
A61P25/06 (EP);
A61P25/08 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P27/02 (EP);
A61P27/06 (EP);
A61P27/12 (EP);
A61P29/00 (EP);
A61P29/02 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
A61P31/04 (EP);
A61P31/06 (EP);
A61P31/12 (EP);
A61P31/18 (EP);
A61P33/00 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P5/14 (EP);
A61P7/00 (EP);
A61P7/02 (EP);
A61P7/06 (EP);
A61P9/00 (EP);
A61P9/02 (EP);
A61P9/04 (EP);
A61P9/06 (EP);
A61P9/08 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
C07D239/34 (EP,US);
C07D239/38 (EP,US);
C07D239/48 (EP,US);
C07D401/04 (EP,US);
C07D401/06 (EP,US);
C07D401/12 (EP,KR,US);
C07D403/04 (EP,US);
C07D403/12 (EP,US);
C07D405/14 (EP,US);
C07D409/12 (EP,US);
C07D413/06 (EP,US);
C07D451/04 (EP,US);
C07D453/02 (EP,US);
|
| Former IPC [2012/06] | C07D239/34, A61K31/505, A61K31/506, A61K31/5377, A61K31/53 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/06] | Extension states | RS | 23.09.2011 | Title | German: | PYRIMIDINVERBINDUNG | [2012/06] | English: | PYRIMIDINE COMPOUND | [2012/06] | French: | COMPOSÉ PYRIMIDINE | [2012/06] | Entry into regional phase | 23.09.2011 | Translation filed | 23.09.2011 | National basic fee paid | 23.09.2011 | Search fee paid | 23.09.2011 | Designation fee(s) paid | 23.09.2011 | Examination fee paid | Examination procedure | 23.09.2011 | Examination requested [2012/06] | 06.02.2013 | Amendment by applicant (claims and/or description) | 22.05.2013 | Despatch of a communication from the examining division (Time limit: M04) | 02.09.2013 | Reply to a communication from the examining division | 01.10.2014 | Application deemed to be withdrawn, date of legal effect [2015/13] | 14.11.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2015/13] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 22.05.2013 | Fees paid | Renewal fee | 15.03.2012 | Renewal fee patent year 03 | 20.03.2013 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.03.2014 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2004018434 (GLAXO GROUP LTD [GB], et al) [I] 1,9-15 * claims 1, 5 *; | [I]WO2005080350 (GLAXO GROUP LTD [GB], et al) [I] 1,9-15* claims 1, 9, 10 * | International search | [A]JP2006501228 (GLAXO GROUP LTD.); | [A]JP2006510597 (MERCK & CO., INC.); | [A]JP2007523207 (GLAXO GROUP LTD.) | by applicant | WO9625397 | WO9709315 | WO9709325 | WO9838171 | US5811428 | US5935966 | WO2004009027 | WO2004018433 | WO2004018434 | WO2004029026 | WO2005075464 | WO2005075440 | WO2005080342 | WO2005080349 | WO2005080350 | WO2005121140 | WO2006043260 | WO2006050476 | WO2007017237 | WO2007017264 | WO2007088168 | WO2007118859 | WO2008027812 | - NATURE, (1990), vol. 346, pages 561 - 564 | - NATURE, (1993), vol. 365, pages 61 - 65 | - SCIENCE, (2005), vol. 310, pages 329 - 332 | - EUROPEAN JOURNAL OF NEUROSCIENCE, (2006), vol. 23, pages 1530 - 1538 | - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (2005), vol. 102, pages 3093 - 3098 | - BRITISH JOURNAL OF PHARMACOLOGY, (2003), vol. 139, pages 775 - 786 | - SCIENCE, (2007), vol. 316, pages 1494 - 1497 | - NATURE, (2005), vol. 434, pages 782 - 786 | - EUROPEAN JOURNAL OF PHARMACOLOGY, (2007), vol. 573, pages 206 - 213 | - BRITISH JOURNAL OF PHARMACOLOGY, (2008), vol. 153, pages 2S6 - 289 | - EXPERT OPINION OF THERAPEUTIC TARGETS, (2007), vol. 11, pages 403 - 409 | - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (2006), vol. 103, pages 696 - 701 | - JOURNAL OF MEDICINAL CHEMISTRY, (1998), vol. 41, pages 413 - 419 | - JOURNAL OF COMBINATORIAL CHEMISTRY, (2004), vol. 6, pages 105 - 111 | - TETRAHEDRON LETTERS, (1997), vol. 3 8, pages 211 - 214 | - PROG. MED., (1985), vol. 5, pages 2157 - 2161 | - DRUG DESIGN, vol. 7, pages 163 - 198 | - Organic Functional Group Preparations, ACADEMIC PRESS INC., (1991), vol. 1 | - Jikken Kagaku Koza, MARUZEN, (2005), vol. 16 | - Jikken Kagaku Koza, MARUZEN, (2005), vol. 14 | - MOLECULAR PHARMACOLOGY, (1995), vol. 48, pages 443 - 450 |